Author:
Borlongan Cesar V.,Sanberg Paul R.
Reference113 articles.
1. Martin JB, Gusella JF (1986) Huntington’s disease: pathenogenesis and management. N Engl J Med 315:1267–1276
2. Shoulson I, Asbury A, McKhann GM, McDonald I (1986) Huntington’s Disease: The disease of the nervous system. Ardmore Medical Books (W. B. Saunders): Philadephia
3. Maragos WF, Young KL, Altman CS, Pocernich CB, Drake J, Butterfield DA, Seif I, Holschneider DP, Chen K, Shih JC (2004) Striatal damage and oxidative stress induced by the mitochondrial toxin malonate are reduced in clorgyline-treated rats and MAO-A deficient mice. Neurochem Res 29(4):741–746
4. The Huntington’s Collaborative Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell 72:971–983
5. Koutouzis TK, Emerich D, Borlongan CV, Freeman TB, Cahill DW, Sanberg PR (1991) Cell transplantation for central nervous system disorders. CRC Crit Rev Neurobiol 3:25–162